TaiMed Biologics
TWD55.00
0
-TWD1.30-2.31% 05:30 Today
Statistics
Day High
56.7
Day Low
54.9
52W High
75.4
52W Low
47
Volume
637,350
Avg. Volume
954,112
Mkt Cap
15.03B
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
Nov 18Expected
Q1 2026
Q2 2026
Next
-0.3
-0.27
-0.25
-0.23
Expected EPS
-0.29596212971999997
Actual EPS
N/A
Financials
-27.44%Profit Margin
Unprofitable611.35MRevenue
-167.78MNet Income
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
TaiMed Biologics Inc., a biotechnology company, develops, manufactures, and commercializes drugs for the treatment and prevention of infectious diseases. The company develops and markets Trogarzo IV infusion and Trogarzo IV push, a monoclonal antibody for HIV treatment. It is also developing TMB-365, a monoclonal antibody used for HIV treatment and prevention which has completed a phase-1 clinical trial; and TMB-365 and TMB-380 combination, a monoclonal antibody combination therapy for HIV that is in phase-1b/2a clinical trial, as well as antibody-drug conjugates for cancer treatment. In addition, the company offers contract development and manufacturing services. It has a research and development agreement with Genentech and Biogen Inc. for Trogarzo TMB-355; and authorizes Samsung Biologics to produce TMB-355. TaiMed Biologics Inc. was incorporated in 2007 and is headquartered in Taipei, Taiwan.
Show More
CEO
Chin-Ming Chang
Employees
799
Country
Taiwan
ISIN
TW0004147004
Listings
0 Comments
Share your thoughts
FAQs
What is TaiMed Biologics stock price today?▼
The current price of 4147.TWO is TWD55.00 TWD — it has decreased by -2.31% in the past 24 hours. Watch TaiMed Biologics stock price performance more closely on the chart.
What is TaiMed Biologics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Taiwan OTC Exchange exchange TaiMed Biologics stocks are traded under the ticker 4147.TWO.
Is TaiMed Biologics stock price growing?▼
4147.TWO stock has fallen by -9.84% compared to the previous week, the month change is a -10.42% fall, over the last year TaiMed Biologics has showed a -21.88% decrease.
What is TaiMed Biologics market cap?▼
Today TaiMed Biologics has the market capitalization of 15.03B
When is the next TaiMed Biologics earnings date?▼
TaiMed Biologics is going to release the next earnings report on November 18, 2026.
What were TaiMed Biologics earnings last quarter?▼
4147.TWO earnings for the last quarter are -0.27 TWD per share, whereas the estimation was -0.23 TWD resulting in a -17.39% surprise. The estimated earnings for the next quarter are N/A TWD per share.
What is TaiMed Biologics revenue for the last year?▼
TaiMed Biologics revenue for the last year amounts to 611.35M TWD.
What is TaiMed Biologics net income for the last year?▼
4147.TWO net income for the last year is -167.78M TWD.
How many employees does TaiMed Biologics have?▼
As of November 3, 2026, the company has 799 employees.
In which sector is TaiMed Biologics located?▼
TaiMed Biologics operates in the Health & Wellness sector.
When did TaiMed Biologics complete a stock split?▼
TaiMed Biologics has not had any recent stock splits.
Where is TaiMed Biologics headquartered?▼
TaiMed Biologics is headquartered in Taipei, Taiwan.